<DOC>
	<DOCNO>NCT02229994</DOCNO>
	<brief_summary>The purpose study psychometric validation self-administered dyspnea questionnaire , usable clinical practice order ass dyspnea impact patient chronic respiratory disease .</brief_summary>
	<brief_title>Development New Tool Dyspnea Measurement Chronic Respiratory Diseases</brief_title>
	<detailed_description>Dyspnea cardinal Respiratory symptom . According ATS dyspnea term use characterize subjective experience breathe discomfort , cover qualitatively distinct sensation vary intensity . The subjective nature dyspnea high complexity determinant explain often moderate correlation obtain physiological data . Dyspnea must therefore measure specifically . The aim study cross-sectional longitudinal psychometric validation self-administered dyspnea questionnaire ( assess impact dyspnea activity restriction ) , usable clinical practice order ass dyspnea alteration adult patient chronic respiratory disease . ( COPD , diffuse interstitial lung disease , Pulmonary arterial hypertension , Cystic fibrosis ) Like psychometric instrument , efficient evaluation dyspnea scale ideally satisfy following require feature : evaluative , discriminant , good reproducibility , high sensitivity change . The desired feature apart content validity reproducibility especially high sensitivity change , particularly follow pulmonary rehabilitation . Thus , questionnaire precisely enable assess benefit rehabilitation 's sustainment maintenance phase .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Dyspnea</mesh_term>
	<mesh_term>Respiration Disorders</mesh_term>
	<mesh_term>Respiratory Tract Diseases</mesh_term>
	<mesh_term>Lung Diseases , Interstitial</mesh_term>
	<criteria>1 ) Sample1 : COPD GOLD / ATS &gt; 2 without major comorbidity Sample 1A : n = 50 : group patient change usual care acute event ( evaluation reproducibility ) Sample1B : n = 60 : patient assess qualify period pulmonary rehabilitation 2 ) Sample 2 ( n = 30 ) : diffuse interstitial lung disease Criteria : Pulmonary Fibrosis : Idiopathic nonspecific interstitial lung disease ( NILD ) accord international criterion ( ATS ) , sarcoidosis parenchymal lesion ( old classification stage II III ) , exceptionally alveolar proteinosis . 3 ) Sample 3 ( n = 30 ) primary secondary arterial pulmonary hypertension ( post embolic ... .. ) . 4 ) Sample4 ( n = 30 ) : Adult Cystic fibrosis . 5 ) patient stable Status ( exacerbation least one month ) 1 ) Patient 18 year 2 ) Inability fill questionnaires 3 ) Other respiratory disease 4 ) leave symptomatic heart failure 5 ) Obesity BMI &gt; 35 kg/m2 6 ) Inability perform PFT ( Pulmonary Function Testing ) 7 ) Pregnant breastfeed woman 8 ) Patient unable consent 9 ) Lack social insurance coverage 10 ) Patient exclusion period another protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Dyspnea</keyword>
	<keyword>Self-administered questionnaire</keyword>
	<keyword>Chronic respiratory disease</keyword>
	<keyword>COPD</keyword>
	<keyword>Diffuse interstitial lung disease</keyword>
	<keyword>Pulmonary arterial hypertension</keyword>
	<keyword>Cystic fibrosis</keyword>
</DOC>